Product Description
Product introduction
Gemibine 1.4g Injection is used in the treatment of non-small cell lung cancer, breast cancer, pancreatic cancer, urinary bladder cancer, and ovarian cancer.
Gemibine 1.4g Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include nausea, vomiting, loss of appetite, hair loss and low blood platelets. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.
Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
Powerful Anticancer TherapyGemibine 1.4 G Injection offers targeted therapy for a variety of major cancers. As a cytotoxic agent, it disrupts cancer cell growth and division, improving treatment outcomes when administered by oncology professionals. Its single-use formulation ensures sterility and patient safety.
How to Prepare and AdministerTo use, reconstitute the white to off-white powder with sterile normal saline or 5% dextrose solution, achieving a neutral pH (6.5-7.5). Administration is strictly intravenous and performed only in medical facilities, under the supervision of a qualified healthcare provider.
Safe Storage and UsageStore Gemibine vials below 25C, protect from direct light, and keep them in their original packaging to maintain their stability. As a prescription-only product, handling and disposal should comply with institutional guidelines for cytotoxic agents.
FAQ's of Gemibine 1.4 G Injection:
Q: How should Gemibine 1.4 G Injection be properly reconstituted before use?
A: Reconstitute the lyophilized powder with sterile normal saline or 5% dextrose solution, following hospital protocol to achieve a neutral pH between 6.5 and 7.5. Mix gently to ensure complete dissolution before intravenous administration.
Q: What is the main indication for using Gemibine Injection?
A: Gemibine Injection is primarily indicated for the treatment of several cancers, including non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer, as prescribed by an oncologist.
Q: When is Gemibine 1.4 G Injection contraindicated?
A: This injection should not be used in patients with known hypersensitivity to gemcitabine or any of the product's excipients. Always review patient history before prescribing.
Q: Where should Gemibine Injection be administered and who can give it?
A: The injection is intended for intravenous use only within hospital or clinic settings, administered by qualified healthcare professionals experienced in chemotherapy.
Q: What are important safety warnings associated with Gemibine?
A: Caution is advised in patients with myelosuppression or liver impairment. Regular monitoring of blood counts and liver function is recommended throughout treatment.
Q: What are the storage requirements for the Gemibine 1.4 G vial?
A: Store the single-use vial below 25C, protected from light and moisture, and keep in its original packaging until use. Discard any unused portion appropriately per cytotoxic handling guidelines.
Q: What are the main benefits of using Gemibine Injection in cancer treatment?
A: Gemibine offers an effective option for disrupting cancer cell growth, enhancing treatment regimens for various solid tumors, and is administered under strict medical supervision to optimize safety and efficacy.